NasdaqGS - Delayed Quote USD
Halozyme Therapeutics, Inc. (HALO)
54.25
+0.70
+(1.31%)
At close: June 6 at 4:00:01 PM EDT
54.49
+0.24
+(0.44%)
After hours: June 6 at 7:48:05 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
503,858
479,064
388,571
240,110
299,440
Investing Cash Flow
-270,464
-262,723
-96,909
-487,005
-406,289
Financing Cash Flow
-221,693
-218,861
-407,987
362,371
77,865
End Cash Position
176,328
115,850
118,370
234,695
119,219
Income Tax Paid Supplemental Data
--
80,618
31,756
16,224
--
Interest Paid Supplemental Data
--
10,565
11,410
6,107
3,296
Capital Expenditure
-8,101
-10,696
-15,294
-4,810
-1,457
Issuance of Debt
--
0
0
1,072,000
784,875
Repayment of Debt
--
0
-13,483
-447,453
-369,064
Repurchase of Capital Stock
--
-250,000
-402,383
-200,002
-350,058
Free Cash Flow
495,757
468,368
373,277
235,300
297,983
12/31/2021 - 3/16/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CORT Corcept Therapeutics Incorporated
69.60
+0.85%
EXEL Exelixis, Inc.
43.03
+1.56%
MRUS Merus N.V.
56.21
+0.36%
ADMA ADMA Biologics, Inc.
20.61
+3.36%
INCY Incyte Corporation
68.77
+2.28%
HRMY Harmony Biosciences Holdings, Inc.
35.60
+1.63%
KRYS Krystal Biotech, Inc.
136.94
+3.26%
BMRN BioMarin Pharmaceutical Inc.
56.65
+2.50%
PTCT PTC Therapeutics, Inc.
52.13
+0.77%
ALNY Alnylam Pharmaceuticals, Inc.
300.83
-2.33%